Minmetals Development Co.Ltd(600058) net profit in 2021 increased by 77%
Minmetals Development Co.Ltd(600058) release performance forecast. The company expects to achieve a net profit of about 475 million yuan attributable to shareholders of Listed Companies in 2021, with a year-on-year increase of about 77%. In 2021, the company's main commodity markets such as steel and iron ore fluctuated greatly. The company quickly responded to market changes, effectively resolved market risks, significantly improved profitability and significantly improved operational efficiency.
Lingyuan Iron & Steel Co.Ltd(600231) net profit in 2021 increased by 65%
Lingyuan Iron & Steel Co.Ltd(600231) release performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company in 2021, which will increase by 360 million yuan compared with the previous year, with a year-on-year increase of about 64.55%. During the reporting period, the company seized the favorable opportunity of the sharp rise in steel prices, and achieved a significant year-on-year increase in enterprise benefits through in-depth benchmarking, tapping potential and vigorously reducing costs.
Lihuayi Weiyuan Chemical Co.Ltd(600955) the net profit in 2021 is expected to increase by 182% - 201%
Lihuayi Weiyuan Chemical Co.Ltd(600955) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company in 2021 will be 2020 million yuan to 2150 million yuan, with a year-on-year increase of 182.48% to 200.65%. In 2021, the company's new phenol ketone plant was put into full production, and the production capacity was greatly improved; At the same time, the market demand of the company's products is strong, and the prices of major products such as phenol, bisphenol A and polycarbonate have increased. The company's sales revenue and net profit increased significantly year-on-year.
Zhejiang Jianye Chemical Co.Ltd(603948) pre increase of net profit in 2021 by 115% - 147%
Zhejiang Jianye Chemical Co.Ltd(603948) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company in 2021 will be 270 million yuan to 310 million yuan, with a year-on-year increase of 114.83% to 146.66%. During the reporting period, affected by the improvement of market supply and demand and the high prosperity of China's chemical industry, the prices of the company's main products such as low-carbon fatty amines increased significantly year-on-year, and the profitability was significantly enhanced.
Guizhou Zhenhua E-Chem Inc(688707) in 2021, the pre profit was 380 million yuan - 430 million yuan, and the loss was reversed year-on-year
Guizhou Zhenhua E-Chem Inc(688707) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will be RMB 380 million to RMB 430 million in 2021, and the loss will be turned into profit year-on-year. The net profit loss in the same period of last year was 169546400 yuan.
In 2021, the new energy vehicle power battery market grew rapidly, and the company's downstream customers had strong demand for cathode materials. On the basis of the stable release of existing production capacity, the company's new production capacity of Yilong phase II project was gradually released, and the annual product sales increased by about 2.8 times year-on-year. The company's sales volume of high nickel ternary materials and the proportion of realized revenue in operating revenue increased significantly compared with 2020.
Shanghai Pharmaceuticals Holding Co.Ltd(601607) oseltamivir phosphate capsule passed the consistency evaluation
Shanghai Pharmaceuticals Holding Co.Ltd(601607) it was announced that Zhongxi Sanwei, a wholly-owned subsidiary of the company, received the notice of approval for drug supplementary application for oseltamivir phosphate capsule issued by the State Food and drug administration, and the drug passed the consistency evaluation of generic drug quality and efficacy. Oseltamivir phosphate capsule is mainly used for the prevention and treatment of influenza A and B.
Spic Yuanda Environmental-Protection Co.Ltd(600292) the net profit in 2021 is expected to increase by 100%
Spic Yuanda Environmental-Protection Co.Ltd(600292) release performance forecast. It is estimated that the company's net profit attributable to shareholders of Listed Companies in 2021 is about 52.71 million yuan, an increase of about 100.19% year-on-year. In 2021, the company's environmental protection project output value increased and the expansion of sewage treatment business made the company's performance increase compared with the same period of last year.
China Telecom Corporation Limited(601728) will determine measures to stabilize the stock price with the controlling shareholders
China Telecom Corporation Limited(601728) announcement: from December 22, 2021 to January 19, 2022, the closing price of the company's shares has been lower than the adjusted net asset value per share for 20 consecutive trading days, which has triggered the starting conditions for the measures to stabilize the stock price. According to the stock price stabilization plan, the company will determine specific stock price stabilization measures with the controlling shareholder China Telecom Corporation Limited(601728) Group Co., Ltd. within 10 trading days from the date when the conditions for the initiation of stock price stabilization measures are triggered (January 19, 2022).
Shanghai Sanyou Medical Co.Ltd(688085) pre increase of net profit in 2021 by 48% - 60%
Shanghai Sanyou Medical Co.Ltd(688085) release performance forecast. It is estimated that the net profit attributable to the owners of the parent company will reach RMB 176 million to 190 million in 2021, with a year-on-year increase of 48.45% to 60.26%. In 2021, the epidemic situation in most areas has been effectively controlled, the orthopedic surgery in the hospital has been carried out in an orderly manner, and the company's promotion channels have further sunk, realizing the steady growth of the company's product sales.
